Literature DB >> 18809840

Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis.

J D Lünemann1, P Huppke, S Roberts, W Brück, J Gärtner, C Münz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18809840      PMCID： PMC2676958          DOI： 10.1212/01.wnl.0000326576.91097.87

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  Environmental risk factors for multiple sclerosis. Part I: the role of infection.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

2.  Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

Authors:  Jan D Lünemann; Nancy Edwards; Paolo A Muraro; Shuhei Hayashi; Jeffrey I Cohen; Christian Münz; Roland Martin
Journal:  Brain       Date:  2006-03-28       Impact factor: 13.501

3.  Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.

Authors:  J L Grogan; A Kramer; A Nogai; L Dong; M Ohde; J Schneider-Mergener; T Kamradt
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

4.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Authors:  K Bickham; C Münz; M L Tsang; M Larsson; J F Fonteneau; N Bhardwaj; R Steinman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Authors:  Sabine Cepok; Dun Zhou; Rajneesh Srivastava; Stefan Nessler; Susanne Stei; Konrad Büssow; Norbert Sommer; Bernhard Hemmer
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

6.  Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Authors:  Brenda Banwell; Lauren Krupp; Julia Kennedy; Raymond Tellier; Silvia Tenembaum; Jayne Ness; Anita Belman; Alexei Boiko; Olga Bykova; Emmanuelle Waubant; Jean K Mah; Cristina Stoian; Marcelo Kremenchutzky; Maria Rita Bardini; Martino Ruggieri; Mary Rensel; Jin Hahn; Bianca Weinstock-Guttman; E Ann Yeh; Kevin Farrell; Mark Freedman; Matti Iivanainen; Meri Sevon; Virender Bhan; Marie-Emmanuelle Dilenge; Derek Stephens; Amit Bar-Or
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

7.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307
  7 in total
  24 in total

Review 1.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

2.  Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

Authors:  Emmanuelle Waubant; Ellen M Mowry; Lauren Krupp; Tanuja Chitnis; E Ann Yeh; Nancy Kuntz; Jayne Ness; Anita Belman; Maria Milazzo; Mark Gorman; Bianca Weinstock-Guttman; Moses Rodriguez; Judith A James
Journal:  Mult Scler       Date:  2012-12-11       Impact factor: 6.312

Review 3.  Epstein-Barr virus in multiple sclerosis.

Authors:  Bridget A Bagert
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

4.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

5.  Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls.

Authors:  Emily C Leibovitch; Cheng-Te Major Lin; Bridgette J Billioux; Jennifer Graves; Emmanuelle Waubant; Steven Jacobson
Journal:  Mult Scler       Date:  2018-03-23       Impact factor: 6.312

6.  Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.

Authors:  J W Lindsey; L M Hatfield; T Vu
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

7.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

Review 8.  Antiviral immune responses: triggers of or triggered by autoimmunity?

Authors:  Christian Münz; Jan D Lünemann; Meghann Teague Getts; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

Review 9.  Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Authors:  Bernd Krone; Frank Oeffner; John M Grange
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Authors:  Daniela F Angelini; Barbara Serafini; Eleonora Piras; Martina Severa; Eliana M Coccia; Barbara Rosicarelli; Serena Ruggieri; Claudio Gasperini; Fabio Buttari; Diego Centonze; Rosella Mechelli; Marco Salvetti; Giovanna Borsellino; Francesca Aloisi; Luca Battistini
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.